Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial-Reference-Cited by-同舟云学术

Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial

Published:2023-12 Issue:12 Volume:176 Page:1682-1684
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Desai Niraj M.¹^ORCID,Leung Sherry G.¹^ORCID,Motter Jennifer D.²^ORCID,Segev Dorry L.³^ORCID,Warren Daniel¹^ORCID,Durand Christine M.⁴^ORCID

Affiliation:

1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland

2. Department of Surgery, New York University Grossman School of Medicine, New York, New York

3. Department of Surgery and Department of Population Health, New York University Grossman School of Medicine, New York, New York

4. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

Funder

Private Donor

National Institutes of Health

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference5 articles.

1. Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients

2. Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C–Viremic Donors to Hepatitis C–Negative Recipients: An Open-Label Nonrandomized Study

3. Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience

4. Ultra‐short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients

5. Outcomes of short‐duration antiviral prophylaxis for hepatitis C positive donor kidney transplants